Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa.
Identifieur interne : 002105 ( Ncbi/Merge ); précédent : 002104; suivant : 002106Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa.
Auteurs : Joël Mossong [Royaume-Uni] ; Erofili Grapsa ; Frank Tanser ; Till B Rnighausen ; Marie-Louise NewellSource :
- AIDS (London, England) [ 1473-5571 ] ; 2013.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Antirétroviraux (usage thérapeutique), Femelle, Humains, Incidence, Infections à VIH (mortalité), Infections à VIH (traitement médicamenteux), Infections à VIH (épidémiologie), Jeune adulte, Modèles théoriques, Mâle, Répartition par sexe, Répartition par âge, République d'Afrique du Sud (épidémiologie), Santé en zone rurale (), Taux de survie, Études transversales.
- MESH :
- mortalité : Infections à VIH.
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Antirétroviraux.
- épidémiologie : Infections à VIH, République d'Afrique du Sud.
- Adolescent, Adulte, Adulte d'âge moyen, Femelle, Humains, Incidence, Jeune adulte, Modèles théoriques, Mâle, Répartition par sexe, Répartition par âge, Santé en zone rurale, Taux de survie, Études transversales.
- Wicri :
- geographic : Afrique du Sud.
English descriptors
- KwdEn :
- Adolescent, Adult, Age Distribution, Anti-Retroviral Agents (therapeutic use), Cross-Sectional Studies, Female, HIV Infections (drug therapy), HIV Infections (epidemiology), HIV Infections (mortality), Humans, Incidence, Male, Middle Aged, Models, Theoretical, Rural Health (statistics & numerical data), Sex Distribution, South Africa (epidemiology), Survival Rate, Young Adult.
- MESH :
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic , epidemiology : South Africa.
- drug therapy : HIV Infections.
- epidemiology : HIV Infections.
- mortality : HIV Infections.
- statistics & numerical data : Rural Health.
- Adolescent, Adult, Age Distribution, Cross-Sectional Studies, Female, Humans, Incidence, Male, Middle Aged, Models, Theoretical, Sex Distribution, Survival Rate, Young Adult.
Abstract
Our study uses sex-specific and age-specific HIV prevalence data from an ongoing population-based demographic and HIV survey to infer HIV incidence and survival in rural KwaZulu-Natal between 2003 and 2011, a period when antiretroviral treatment (ART) was rolled out on a large scale.
DOI: 10.1097/01.aids.0000432475.14992.da
PubMed: 23842131
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001189
- to stream PubMed, to step Curation: 001189
- to stream PubMed, to step Checkpoint: 001189
Links to Exploration step
pubmed:23842131Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa.</title><author><name sortKey="Mossong, Joel" sort="Mossong, Joel" uniqKey="Mossong J" first="Joël" last="Mossong">Joël Mossong</name><affiliation wicri:level="1"><nlm:affiliation>aAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, KwaZulu-Natal, South Africa bDepartment of Global Health and Population, Harvard School of Public Health, Harvard University, Boston, Massachusetts, USA cFaculty of Medicine, University of Southampton, Southampton, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>aAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, KwaZulu-Natal, South Africa bDepartment of Global Health and Population, Harvard School of Public Health, Harvard University, Boston, Massachusetts, USA cFaculty of Medicine, University of Southampton, Southampton</wicri:regionArea><wicri:noRegion>Southampton</wicri:noRegion></affiliation></author><author><name sortKey="Grapsa, Erofili" sort="Grapsa, Erofili" uniqKey="Grapsa E" first="Erofili" last="Grapsa">Erofili Grapsa</name></author><author><name sortKey="Tanser, Frank" sort="Tanser, Frank" uniqKey="Tanser F" first="Frank" last="Tanser">Frank Tanser</name></author><author><name sortKey="B Rnighausen, Till" sort="B Rnighausen, Till" uniqKey="B Rnighausen T" first="Till" last="B Rnighausen">Till B Rnighausen</name></author><author><name sortKey="Newell, Marie Louise" sort="Newell, Marie Louise" uniqKey="Newell M" first="Marie-Louise" last="Newell">Marie-Louise Newell</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23842131</idno><idno type="pmid">23842131</idno><idno type="doi">10.1097/01.aids.0000432475.14992.da</idno><idno type="wicri:Area/PubMed/Corpus">001189</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001189</idno><idno type="wicri:Area/PubMed/Curation">001189</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001189</idno><idno type="wicri:Area/PubMed/Checkpoint">001189</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001189</idno><idno type="wicri:Area/Ncbi/Merge">002105</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa.</title><author><name sortKey="Mossong, Joel" sort="Mossong, Joel" uniqKey="Mossong J" first="Joël" last="Mossong">Joël Mossong</name><affiliation wicri:level="1"><nlm:affiliation>aAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, KwaZulu-Natal, South Africa bDepartment of Global Health and Population, Harvard School of Public Health, Harvard University, Boston, Massachusetts, USA cFaculty of Medicine, University of Southampton, Southampton, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>aAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, KwaZulu-Natal, South Africa bDepartment of Global Health and Population, Harvard School of Public Health, Harvard University, Boston, Massachusetts, USA cFaculty of Medicine, University of Southampton, Southampton</wicri:regionArea><wicri:noRegion>Southampton</wicri:noRegion></affiliation></author><author><name sortKey="Grapsa, Erofili" sort="Grapsa, Erofili" uniqKey="Grapsa E" first="Erofili" last="Grapsa">Erofili Grapsa</name></author><author><name sortKey="Tanser, Frank" sort="Tanser, Frank" uniqKey="Tanser F" first="Frank" last="Tanser">Frank Tanser</name></author><author><name sortKey="B Rnighausen, Till" sort="B Rnighausen, Till" uniqKey="B Rnighausen T" first="Till" last="B Rnighausen">Till B Rnighausen</name></author><author><name sortKey="Newell, Marie Louise" sort="Newell, Marie Louise" uniqKey="Newell M" first="Marie-Louise" last="Newell">Marie-Louise Newell</name></author></analytic><series><title level="j">AIDS (London, England)</title><idno type="eISSN">1473-5571</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Anti-Retroviral Agents (therapeutic use)</term><term>Cross-Sectional Studies</term><term>Female</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (epidemiology)</term><term>HIV Infections (mortality)</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Models, Theoretical</term><term>Rural Health (statistics & numerical data)</term><term>Sex Distribution</term><term>South Africa (epidemiology)</term><term>Survival Rate</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antirétroviraux (usage thérapeutique)</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Infections à VIH (mortalité)</term><term>Infections à VIH (traitement médicamenteux)</term><term>Infections à VIH (épidémiologie)</term><term>Jeune adulte</term><term>Modèles théoriques</term><term>Mâle</term><term>Répartition par sexe</term><term>Répartition par âge</term><term>République d'Afrique du Sud (épidémiologie)</term><term>Santé en zone rurale ()</term><term>Taux de survie</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>South Africa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Rural Health</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirétroviraux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à VIH</term><term>République d'Afrique du Sud</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Age Distribution</term><term>Cross-Sectional Studies</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Models, Theoretical</term><term>Sex Distribution</term><term>Survival Rate</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Jeune adulte</term><term>Modèles théoriques</term><term>Mâle</term><term>Répartition par sexe</term><term>Répartition par âge</term><term>Santé en zone rurale</term><term>Taux de survie</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Afrique du Sud</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Our study uses sex-specific and age-specific HIV prevalence data from an ongoing population-based demographic and HIV survey to infer HIV incidence and survival in rural KwaZulu-Natal between 2003 and 2011, a period when antiretroviral treatment (ART) was rolled out on a large scale.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23842131</PMID><DateCreated><Year>2013</Year><Month>09</Month><Day>13</Day></DateCreated><DateCompleted><Year>2014</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5571</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>15</Issue><PubDate><Year>2013</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>AIDS (London, England)</Title><ISOAbbreviation>AIDS</ISOAbbreviation></Journal><ArticleTitle>Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa.</ArticleTitle><Pagination><MedlinePgn>2471-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/01.aids.0000432475.14992.da</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our study uses sex-specific and age-specific HIV prevalence data from an ongoing population-based demographic and HIV survey to infer HIV incidence and survival in rural KwaZulu-Natal between 2003 and 2011, a period when antiretroviral treatment (ART) was rolled out on a large scale.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Catalytic mathematical model for estimating HIV incidence and differential survival in HIV-infected persons on multiple rounds of HIV seroprevalence.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We evaluate trends of HIV incidence and survival by estimating parameters separately for women and men aged 15-49 years during three calendar periods (2003-2005, 2006-2008, 2009-2011) reflecting increasing ART coverage. We compare model-based estimates of HIV incidence with observed cohort-based estimates from the longitudinal HIV surveillance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median survival after HIV infection increased significantly between 2003-2005 and 2009-2011 from 10.0 [95% confidence interval (CI) 8.8-11.2] to 14.2 (95% CI 12.6-15.8) years in women (P < 0.001) and from 10.0 (95% CI 9.2-10.8) to 14.0 (95% CI 10.6-17.4) years in men (P = 0.02). Our model suggests no statistically significant reduction of HIV incidence in the age-group 15-49 years in 2009-2011 compared with 2003-2005. Age-specific and sex-specific model-based HIV incidence estimates were in good agreement with observed cohort-based estimates from the ongoing HIV surveillance.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our catalytic modelling approach using cross-sectional age-specific HIV prevalence data could be useful to monitor trends of HIV incidence and survival in other African settings with a high ART coverage.</AbstractText><CopyrightInformation>© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mossong</LastName><ForeName>Joël</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>aAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, KwaZulu-Natal, South Africa bDepartment of Global Health and Population, Harvard School of Public Health, Harvard University, Boston, Massachusetts, USA cFaculty of Medicine, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grapsa</LastName><ForeName>Erofili</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Tanser</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Bärnighausen</LastName><ForeName>Till</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Newell</LastName><ForeName>Marie-Louise</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>097410</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 HD058482</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>050534</GrantID><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>1R01-HD058482-01</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>AIDS</MedlineTA><NlmUniqueID>8710219</NlmUniqueID><ISSNLinking>0269-9370</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2010 Jan 2;24(1):147-52</RefSource><PMID Version="1">19915447</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiology. 2010 Sep;21(5):685-97</RefSource><PMID Version="1">20699682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(5):e5720</RefSource><PMID Version="1">19479050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2013 Sep 10;27(14):2301-5</RefSource><PMID Version="1">23669155</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008;3(11):e3640</RefSource><PMID Version="1">18982059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2009 Oct;87(10):754-62</RefSource><PMID Version="1">19876542</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2008 Apr 8;5(4):e80</RefSource><PMID Version="1">18590346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008;3(3):e1711</RefSource><PMID Version="1">18320032</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2007 Jul 11;21(11):1467-72</RefSource><PMID Version="1">17589193</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2013;10(4):e1001418</RefSource><PMID Version="1">23585736</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2011 Mar 27;25(6):861-3</RefSource><PMID Version="1">21358377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 2008 Oct;37(5):956-62</RefSource><PMID Version="1">17998242</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Popul Health Metr. 2011 Aug 05;9:47</RefSource><PMID Version="1">21819602</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 22;339(6122):966-71</RefSource><PMID Version="1">23430656</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2007 Nov;21 Suppl 6:S55-63</RefSource><PMID Version="1">18032940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Science. 2013 Feb 22;339(6122):961-5</RefSource><PMID Version="1">23430655</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2002 Jun 1;359(9321):1896-903</RefSource><PMID Version="1">12057552</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1996 Dec;10(14):1689-97</RefSource><PMID Version="1">8970690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2003 Jan 25;326(7382):219</RefSource><PMID Version="1">12543843</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stat Med. 2001 Jul 15;20(13):2003-16</RefSource><PMID Version="1">11427956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2007 Nov;21 Suppl 6:S87-96</RefSource><PMID Version="1">18032944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1996 Aug 1;144(3):214-23</RefSource><PMID Version="1">8686690</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stat Med. 2007 Jan 30;26(2):320-35</RefSource><PMID Version="1">16625518</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiol Rev. 2010;32:26-37</RefSource><PMID Version="1">20203104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiol Infect. 2007 Aug;135(6):922-32</RefSource><PMID Version="1">17217548</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2008 Jan 2;22(1):139-44</RefSource><PMID Version="1">18090402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Hyg (Lond). 1985 Oct;95(2):419-36</RefSource><PMID Version="1">4067297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2008 Mar 25;5(3):e74</RefSource><PMID Version="1">18366252</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin HIV AIDS. 2011 Mar;6(2):102-7</RefSource><PMID Version="1">21505383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2010;5(6):e11094</RefSource><PMID Version="1">20559425</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2010 Feb 20;24(4):593-602</RefSource><PMID Version="1">20071975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(3):e17535</RefSource><PMID Version="1">21408182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stat Med. 1986 Nov-Dec;5(6):573-8</RefSource><PMID Version="1">3823665</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 1998 Feb 12;12(3):315-22</RefSource><PMID Version="1">9517995</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2012;9(7):e1001245</RefSource><PMID Version="1">22802730</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2009 Apr;25(4):405-9</RefSource><PMID Version="1">19320571</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="Y">Models, Theoretical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012423" MajorTopicYN="N">Rural Health</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013019" MajorTopicYN="N" Type="Geographic">South Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3815011</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23842131</ArticleId><ArticleId IdType="doi">10.1097/01.aids.0000432475.14992.da</ArticleId><ArticleId IdType="pmc">PMC3815011</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><noCountry><name sortKey="B Rnighausen, Till" sort="B Rnighausen, Till" uniqKey="B Rnighausen T" first="Till" last="B Rnighausen">Till B Rnighausen</name><name sortKey="Grapsa, Erofili" sort="Grapsa, Erofili" uniqKey="Grapsa E" first="Erofili" last="Grapsa">Erofili Grapsa</name><name sortKey="Newell, Marie Louise" sort="Newell, Marie Louise" uniqKey="Newell M" first="Marie-Louise" last="Newell">Marie-Louise Newell</name><name sortKey="Tanser, Frank" sort="Tanser, Frank" uniqKey="Tanser F" first="Frank" last="Tanser">Frank Tanser</name></noCountry><country name="Royaume-Uni"><noRegion><name sortKey="Mossong, Joel" sort="Mossong, Joel" uniqKey="Mossong J" first="Joël" last="Mossong">Joël Mossong</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002105 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002105 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:23842131
|texte= Modelling HIV incidence and survival from age-specific seroprevalence after antiretroviral treatment scale-up in rural South Africa.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:23842131" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |